Scribd
Upload
93 views1 page

Keygene N.V. Enters Into A Settlement and License Agreement With Floragenex Inc

Keygene N.V. and Floragenex Inc. announced that they have entered into a license agreement in the field of Sequence Based Genotyping and will dismiss the patent infringement lawsuit filed by KeyGene against Floragenex in 2011. Under the terms, Floragenex will obtain a non-exclusive royalty bearing license to KeyGene's intellectual property and will continue applying the Restriction-site Associated DNA method in specified fields including non-commercial research. Both companies believe that genotyping with next generation sequencing holds promise for applications across species.

Uploaded by

api-99034713
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
93 views1 page

Keygene N.V. Enters Into A Settlement and License Agreement With Floragenex Inc

Keygene N.V. and Floragenex Inc. announced that they have entered into a license agreement in the field of Sequence Based Genotyping and will dismiss the patent infringement lawsuit filed by KeyGene against Floragenex in 2011. Under the terms, Floragenex will obtain a non-exclusive royalty bearing license to KeyGene's intellectual property and will continue applying the Restriction-site Associated DNA method in specified fields including non-commercial research. Both companies believe that genotyping with next generation sequencing holds promise for applications across species.

Uploaded by

api-99034713
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

Wageningen/Portland, November 5, 2012

Keygene N.V. enters into a settlement and license agreement with Floragenex Inc.
Keygene N.V. and Floragenex Inc. announced today that they have entered into a license agreement in the field of Sequence Based Genotyping (SBG). The agreement includes dismissal of the patent infringement lawsuit filed by KeyGene in 2011 against Floragenex in the U.S. District Court for the District of Oregon. Under terms of the agreement, Floragenex will obtain a non-exclusive royalty bearing license to KeyGenes intellectual property. Floragenex will continue to apply the Restriction-site Associated DNA (RAD) method in specified fields, including non-commercial and academic research in all species. The agreement strengthens the position of Floragenex as leader in RADseq applications and extends its portfolio of research service offerings. Financial terms were not disclosed. During the last decade, KeyGene has invested substantially in research and development of its molecular breeding technology platform and IPR portfolio. We are very pleased to have Floragenex join our growing number of licensees said Arjen J. van Tunen, CEO of KeyGene. This settlement and license agreement demonstrates KeyGene's leading position in this field and allows us to focus on further licensing opportunities in the Sequence Based Breeding market. Floragenex and KeyGene share the belief that genotyping with next generation sequencing technology holds tremendous promise for applications in all species. The power of sequencing platforms today and in the future open up new markets and opportunities for RADseq and similar applications as substitutes for fixed content genotyping arrays, said Rick Nipper, the President of Floragenex. We are pleased to build a relationship with KeyGene that provides clarity around Intellectual Property in these fields and advances the strategic business objectives of both companies. About KeyGene KeyGene is a privately owned, innovative molecular genetics Ag Biotech company with a primary focus on the improvement of 6F (Food, Feed, Fiber, Fuel, Flowers and Fun) crops. KeyGenes passion is a Green Gene Revolution approach to explore and exploit natural genetic variation in vegetable and other 6F crops. KeyGene delivers sustainable responses to the worlds needs for yield stability & quality of vegetable and field crops. It supports its strategic partners with cutting edge breeding technologies and plant-based trait platforms to meet their needs. KeyGene performs strategic and applied research with more than 135 employees from all over the world, with state of the art facilities and equipment. KeyGene has its headquarters in Wageningen, the Netherlands, a subsidiary in Rockville, USA and a Joint Lab with the Shanghai Institute of Biological Sciences in Shanghai, China. About Floragenex Floragenex is a privately held genomics company focused on bringing leading edge sequencing and bioinformatics capabilities to researchers working in species across the tree of life. Floragenex has applied its RADseq technology in over 70 plant, animal, and microbial species to answer a wide range of questions. With a lab and offices in Oregon, and customers around the world, Floragenex delivers results for commercial, academic, and government researchers interested in genomic applications in agriculture, ecology, evolutionary biology, and biomedical research. For more information please contact Mrs. Niclaudi Boshoven nbo@keygene.com www.keygene.com Rick Nipper President, Floragenex rick@floragenex.com www.floragenex.com

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy